Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
Recent: |
|
Past: |
|
The allegations involving the Stanford president and other recent cases herald a public arrival for the awareness of image manipulation as a serious problem in science. → Read More
Don’t expect the fundamental problems in science publishing to go away without an effort to address their root causes: mainly the publish-or-perish culture. → Read More
Given the maelstrom surrounding He Jiankui’s claims, should any journals even consider papers from him? And if they do, what should they keep in mind? → Read More
"There was a lack of awareness of the scale of the problems" in scientific publications, said the new head of ethics for a publisher of more than 250 academic journals. → Read More
Harvard Medical School and Brigham and Women’s Hospital have recommended that 31 papers from a former lab director be retracted from medical journals. → Read More
One of the medical world’s most respected expert bodies is in turmoil as its annual meeting gets underway after its governing board voted to expel a member. → Read More
The revelation that a top Memorial Sloan Kettering official failed to disclose lucrative financial conflicts shows it's time for journals to do more. → Read More
Dr. H. Gilbert Welch has resigned from his faculty position at Dartmouth College after an investigation concluded that he had committed research misconduct. → Read More
The maker of an artificial hip, which has been taken off the market, demanded the retraction of an article that harshly criticized a study of the device. → Read More
"Killing these resources to save a few hundred thousand dollars per year is a penny-wise, pound-foolish decision, and your health and mine will be poorer for it," said a critic of the decision to shut down the government guidelines repository. → Read More
Hologic said it "strongly disputes" Minerva's assertions about biased patient selection, and the company's CFO said the new data would help his sales force “be much more competitive in the marketplace.” → Read More
Authors for Harrison’s Principles of Internal Medicine received more than $11 million between 2009 and 2013 from makers of drugs and medical devices — not a penny of which was disclosed to readers. → Read More
If companies and their investors aren’t tracking peer review sites, they may be the last to know when industry-funded research is called into question. → Read More
A new paper argues that journal publishers should become much more transparent about their peer review practices. → Read More
The False Claims Act is being used for a new purpose: putting universities on the hook for grant money that went to researchers found guilty of fraud. → Read More
China has announced two new crackdowns on research misconduct — one of which could lead to executions for scientists who doctor their data. → Read More
The rules fail to make data sharing mandatory for papers to be published, which raises the prospect that some authors might decide to ignore the hint. → Read More
A flaw in a young researcher's project wasn't the study's death knell, thanks to his willingness to own the embarrassing mistake and make it right. → Read More
When scientists working for Swedish biotech firm WntResearch spotted errors in their paper they retracted it — and offered investors their money back, too. → Read More
From mislabeled antibodies to watered-down catalysts, problems with lab supplies have wasted labs’ resources and scuppered their research findings. → Read More